NCT02158819

Brief Summary

The purpose and primary objective of this study is to compare health economic outcomes between the use of a patient-matched cutting guide (Visionaire) versus the use of standard instrumentation in Total Knee Arthroplasty(TKA). Data will be collected pre-operatively, intra-operatively and post operatively up until and including the six week post-operative assessment. The secondary objectives of the study are to compare safety and early readmission rates between the two techniques. The study hypothesis is that there is no difference in the cost of the episode of care from hospital admission to discharge, including pre-operative radiology costs and cost of resources, with the Visonaire patient-matched cutting guide compared to standard instrumentation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2014

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 9, 2014

Completed
1 month until next milestone

Study Start

First participant enrolled

July 9, 2014

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2017

Completed
Last Updated

January 8, 2019

Status Verified

January 1, 2019

Enrollment Period

2.9 years

First QC Date

June 5, 2014

Last Update Submit

January 7, 2019

Conditions

Keywords

VisionaireHealth EconomicsDegenerative arthritistotal knee arthroplasty

Outcome Measures

Primary Outcomes (1)

  • Cost of the episode of care from admission to hospital to discharge

    The cost of the episode of care from admission to hospital to discharge , including pre-operative radiology costs and costs associated with Visionaire and will incorporate the costs of time, number of instruments utilised, blood transfusion requirements, length of stay and pre-operative xray and MRI costs.

    up to 1 week

Secondary Outcomes (1)

  • Percentage of patients that experience short term complications and/or early readmissions

    up to 6 weeks

Study Arms (2)

TKA with standard instrumentation

NO INTERVENTION

This arm consists of the Genesis II Total knee implant system or the Legion Primary total knee system with standard instrumentation

Total knee arthroplasty with Visionaire

ACTIVE COMPARATOR

This arm will consist of the Genesis II Total Knee Implant System or Legion Primary Total Knee System with the Visionaire patient-matched instrumentation

Device: Total knee arthroplasty with Visionaire

Interventions

Patient Specific Instrumentation

Total knee arthroplasty with Visionaire

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Degenerative arthritis of the knee requiring unilateral primary Total Knee Arthroplasty in subjects for whom the use of patient-matched cutting guides or standard instrumentation are, in the surgeon's opinion, clinically appropriate and acceptable forms of treatment;
  • Patient is of legal age to consent and is skeletally mature;
  • The patient is able to fully understand the purpose of the trial, and his/her role as a participant in the study

You may not qualify if:

  • Patient is known to have poor bone stock making a Total Knee Arthroplasty unjustifiable.
  • Patient is immuno-suppressed.
  • Patient has physical, emotional or neurological conditions that would compromise the subject's compliance with postoperative rehabilitation and follow-up.
  • Patient is pregnant or may become pregnant during the course of the study, or is lactating.
  • Patient has a history of prior ipsilateral major knee surgery (e.g. arthroplasty, high tibial osteotomy, or tibial plateau fracture). Minor prior procedures such as Anterior Cruciate Ligament repair, meniscectomy, or arthroscopy are not excluded.
  • Patient has active, localized or systemic infection.
  • Patient is severely overweight (BMI \>40).
  • Patient is a prisoner.
  • Patient has had a total joint arthroplasty of the contralateral limb in the last 12 months.
  • Patient presently identified with future need for bilateral TKA within the next twenty-four months.
  • Patient has a known or suspected hypersensitivity/allergy to foreign materials contained in the implant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Life Bay View Hospital

Mossel Bay, Cape Town, 6506, South Africa

Location

Sunninghill Hospital

Johannesburg, Gauteng, South Africa

Location

Pretoria East Hospital

Pretoria, Gauteng, South Africa

Location

Private Practice

Durban, KwaZulu-Natal, 4001, South Africa

Location

Life Claremont Hospital

Cape Town, Western Cape, South Africa

Location

MeSH Terms

Conditions

Osteoarthritis, KneeOsteoarthritis

Interventions

Arthroplasty, Replacement, Knee

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Andrew Baker

    Private Practice

    PRINCIPAL INVESTIGATOR
  • Lieth Stewart

    Life Claremont Hospital

    PRINCIPAL INVESTIGATOR
  • Willem Tollig

    Pretoria East Hospital

    PRINCIPAL INVESTIGATOR
  • Michael Barrow

    Sunninghill Hospital

    PRINCIPAL INVESTIGATOR
  • Dan Potgieter

    Life Bay View Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2014

First Posted

June 9, 2014

Study Start

July 9, 2014

Primary Completion

May 15, 2017

Study Completion

May 15, 2017

Last Updated

January 8, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations